PRVAPrivia Health Group, Inc.

Nasdaq priviahealth.com


$ 19.18 $ 0.07 (0.37 %)    

Friday, 19-Jul-2024 15:59:55 EDT
QQQ $ 475.02 $ -4.25 (-0.89 %)
DIA $ 402.92 $ -3.77 (-0.93 %)
SPY $ 548.99 $ -3.67 (-0.66 %)
TLT $ 92.97 $ -0.55 (-0.59 %)
GLD $ 221.79 $ -4.05 (-1.79 %)
$ 19.17
$ 19.17
$ 0.00 x 0
$ 0.00 x 0
$ 18.85 - $ 19.18
$ 15.92 - $ 28.10
884,316
na
2.4B
$ 0.76
$ 127.93
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-25-2022 12-31-2021 10-K
11 11-08-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-28-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 evercore-isi-group-maintains-outperform-on-privia-health-gr-lowers-price-target-to-20

Evercore ISI Group analyst Elizabeth Anderson maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and lowers the pric...

 baird-initiates-coverage-on-privia-health-gr-with-outperform-rating-announces-price-target-of-23

Baird analyst Michael Ha initiates coverage on Privia Health Gr (NASDAQ:PRVA) with a Outperform rating and announces Price T...

 barclays-maintains-equal-weight-on-privia-health-gr-lowers-price-target-to-19

Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and lowers the price target from $2...

 truist-securities-maintains-buy-on-privia-health-gr-lowers-price-target-to-24

Truist Securities analyst Jailendra Singh maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target fr...

 canaccord-genuity-maintains-buy-on-privia-health-gr-lowers-price-target-to-26

Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from...

 privia-health-gr-q1-2024-adj-eps-018-beats-005-estimate-sales-415243m-miss-679999m-estimate

Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.0...

 stifel-maintains-buy-on-privia-health-gr-lowers-price-target-to-24

Stifel analyst Craig Jones maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $28 to $24.

 citigroup-initiates-coverage-on-privia-health-gr-with-buy-rating-announces-price-target-of-25

Citigroup analyst Daniel Grosslight initiates coverage on Privia Health Gr (NASDAQ:PRVA) with a Buy rating and announces Pri...

 canaccord-genuity-maintains-buy-on-privia-health-gr-lowers-price-target-to-37

Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from...

 jp-morgan-maintains-overweight-on-privia-health-gr-lowers-price-target-to-30

JP Morgan analyst Lisa Gill maintains Privia Health Gr (NASDAQ:PRVA) with a Overweight and lowers the price target from $38 ...

 barclays-initiates-coverage-on-privia-health-gr-with-equal-weight-rating-announces-price-target-of-22

Barclays analyst Andrew Mok initiates coverage on Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight rating and announces Pr...

 ubs-maintains-buy-on-privia-health-gr-lowers-price-target-to-29

UBS analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $31 to $29.

 td-cowen-maintains-outperform-on-privia-health-gr-lowers-price-target-to-26

TD Cowen analyst Gary Taylor maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and lowers the price target from $30...